GeoPolitics Pulse

The Heartbeat of World events

Bevacizumab Biosimilar Receives Approval in the European Union – OncLive

by ·

… European Union–sourced bevacizumab plus paclitaxel and carboplatin. Findings showed that patients treated with Avzivi plus chemotherapy (n = 325) …Read More

Related posts:

  1. Illuccix PSMA-PET Imaging Agent Receives UK Approval in Prostate Cancer – OncLive
  2. Selinexor Receives Approval in South Korea for Multiple Myeloma – OncLive
  3. Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the …
  4. Tarlatamab Earns UK Approval for Previously Treated ES-SCLC – OncLive
  5. Celltrion Expands Biosimilar Portfolio in the European Union Following European … – Business Wire